News & Updates
Filter by Specialty:
Is first-line lazertinib monotherapy a potential new SoC for EGFRm NSCLC?
Patients with EGFR-mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) exhibited significantly improved progression-free survival (PFS) when treated with lazertinib compared with gefitinib in the first-line setting, results of the LASER301 trial showed.
Is first-line lazertinib monotherapy a potential new SoC for EGFRm NSCLC?
10 Feb 2023
Machine-learning algorithm detects diabetes class from ECG
A machine-learning algorithm dubbed DiaBeats demonstrates accuracy in identifying diabetes and prediabetes noninvasively using electrocardiogram (ECG) signal data, reports a study.
Machine-learning algorithm detects diabetes class from ECG
10 Feb 2023
Herbal combo regimen shows promise for ulcerative colitis
A combination regimen comprising two herbal extracts – curcumin and Qing Dai (QD) – have shown potential in the treatment of active* ulcerative colitis (UC), according to two trials from Israel presented at Crohn’s & Colitis Congress (CCC) 2023.
Herbal combo regimen shows promise for ulcerative colitis
10 Feb 2023
Alcohol drinking blamed for rise in colorectal cancer cases among young adults
Consumption of alcohol appears to be a risk factor for early-onset colorectal cancer and has driven an increase in the incidence of colorectal cancer among young adults, as shown in a study.